J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Gen Virol 84 (2003), 2293-2303; DOI 10.1099/vir.0.18942-0

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Broyles, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Broyles, S. S.
Agricola
Right arrow Articles by Broyles, S. S.
© 2003 Society for General Microbiology

Review article

Vaccinia virus transcription

Steven S. Broyles

Department of Biochemistry, Purdue University, West Lafayette, IN 47907-1153, USA

Correspondence
Steven Broyles
broyles{at}purdue.edu

Vaccinia virus replication takes place in the cytoplasm of the host cell. The nearly 200 kbp genome owes part of its complexity to encoding most of the proteins involved in genome and mRNA synthesis. The multisubunit vaccinia virus RNA polymerase requires a separate set of virus-encoded proteins for the transcription of the early, intermediate and late classes of genes. Cell fractionation studies have provided evidence for a role for host cell proteins in the initiation and termination of vaccinia virus intermediate and late gene transcription. Vaccinia virus resembles nuclear DNA viruses in the integration of viral and host proteins for viral mRNA synthesis, yet is markedly less reliant on host proteins than its nuclear counterparts.

Published ahead of print on 28 May 2003 as DOI 10.1099/vir.0.18942-0




This article has been cited by other articles:


Home page
 J. Gen. Virol.Home page
K. L. Roberts, A. Breiman, G. C. Carter, H. A. Ewles, M. Hollinshead, M. Law, and G. L. Smith
Acidic residues in the membrane-proximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycan-mediated disruption of the extracellular enveloped virus outer membrane
J. Gen. Virol., July 1, 2009; 90(7): 1582 - 1591.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
B. A. Knutson, J. Oh, and S. S. Broyles
Downregulation of vaccinia virus intermediate and late promoters by host transcription factor YY1
J. Gen. Virol., July 1, 2009; 90(7): 1592 - 1599.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
C. Myskiw, J. Arsenio, R. van Bruggen, Y. Deschambault, and J. Cao
Vaccinia Virus E3 Suppresses Expression of Diverse Cytokines through Inhibition of the PKR, NF-{kappa}B, and IRF3 Pathways
J. Virol., July 1, 2009; 83(13): 6757 - 6768.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
D. Byrne, R. Grzela, A. Lartigue, S. Audic, S. Chenivesse, S. Encinas, J.-M. Claverie, and C. Abergel
The polyadenylation site of Mimivirus transcripts obeys a stringent 'hairpin rule'
Genome Res., July 1, 2009; 19(7): 1233 - 1242.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. Assarsson, J. A. Greenbaum, M. Sundstrom, L. Schaffer, J. A. Hammond, V. Pasquetto, C. Oseroff, R. C. Hendrickson, E. J. Lefkowitz, D. C. Tscharke, et al.
Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes
PNAS, February 12, 2008; 105(6): 2140 - 2145.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
C. Myskiw, Y. Deschambault, K. Jefferies, R. He, and J. Cao
Aurintricarboxylic Acid Inhibits the Early Stage of Vaccinia Virus Replication by Targeting both Cellular and Viral Factors
J. Virol., March 15, 2007; 81(6): 3027 - 3032.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
E. Brown, T. G. Senkevich, and B. Moss
Vaccinia Virus F9 Virion Membrane Protein Is Required for Entry but Not Virus Assembly, in Contrast to the Related L1 Protein
J. Virol., October 1, 2006; 80(19): 9455 - 9464.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
B. A. Knutson, X. Liu, J. Oh, and S. S. Broyles
Vaccinia Virus Intermediate and Late Promoter Elements Are Targeted by the TATA-Binding Protein
J. Virol., July 15, 2006; 80(14): 6784 - 6793.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
R. Rahbar, T. T. Murooka, A. A. Hinek, C. L. Galligan, A. Sassano, C. Yu, K. Srivastava, L. C. Platanias, and E. N. Fish
Vaccinia Virus Activation of CCR5 Invokes Tyrosine Phosphorylation Signaling Events That Support Virus Replication
J. Virol., July 15, 2006; 80(14): 7245 - 7259.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. L. Najera, C. E. Gomez, E. Domingo-Gil, M. M. Gherardi, and M. Esteban
Cellular and Biochemical Differences between Two Attenuated Poxvirus Vaccine Candidates (MVA and NYVAC) and Role of the C7L Gene.
J. Virol., June 1, 2006; 80(12): 6033 - 6047.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
H. Ludwig, Y. Suezer, Z. Waibler, U. Kalinke, B. S. Schnierle, and G. Sutter
Double-stranded RNA-binding protein E3 controls translation of viral intermediate RNA, marking an essential step in the life cycle of modified vaccinia virus Ankara.
J. Gen. Virol., May 1, 2006; 87(Pt 5): 1145 - 1155.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. Parrish and B. Moss
Characterization of a Vaccinia Virus Mutant with a Deletion of the D10R Gene Encoding a Putative Negative Regulator of Gene Expression
J. Virol., January 15, 2006; 80(2): 553 - 561.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
W. Resch and B. Moss
The Conserved Poxvirus L3 Virion Protein Is Required for Transcription of Vaccinia Virus Early Genes
J. Virol., December 1, 2005; 79(23): 14719 - 14729.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
M. M. Gherardi and M. Esteban
Recombinant poxviruses as mucosal vaccine vectors
J. Gen. Virol., November 1, 2005; 86(11): 2925 - 2936.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. Oh and S. S. Broyles
Host Cell Nuclear Proteins Are Recruited to Cytoplasmic Vaccinia Virus Replication Complexes
J. Virol., October 15, 2005; 79(20): 12852 - 12860.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
H. Ludwig, J. Mages, C. Staib, M. H. Lehmann, R. Lang, and G. Sutter
Role of Viral Factor E3L in Modified Vaccinia Virus Ankara Infection of Human HeLa Cells: Regulation of the Virus Life Cycle and Identification of Differentially Expressed Host Genes
J. Virol., February 15, 2005; 79(4): 2584 - 2596.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. C. Katsafanas and B. Moss
Vaccinia Virus Intermediate Stage Transcription Is Complemented by Ras-GTPase-activating Protein SH3 Domain-binding Protein (G3BP) and Cytoplasmic Activation/Proliferation-associated Protein (p137) Individually or as a Heterodimer
J. Biol. Chem., December 10, 2004; 279(50): 52210 - 52217.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. C. Harrison, B. Alberts, E. Ehrenfeld, L. Enquist, H. Fineberg, S. L. McKnight, B. Moss, M. O'Donnell, H. Ploegh, S. L. Schmid, et al.
Perspective: Discovery of antivirals against smallpox
PNAS, August 3, 2004; 101(31): 11178 - 11192.
[Full Text] [PDF]

Home page
 J. Virol.Home page
S. S. Broyles, M. Kremer, and B. A. Knutson
Antiviral Activity of Distamycin A against Vaccinia Virus Is the Result of Inhibition of Postreplicative mRNA Synthesis
J. Virol., February 15, 2004; 78(4): 2137 - 2141.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2003 by the Society for General Microbiology.